REDUCED IN-VITRO SUSCEPTIBILITY TO MEFLOQUINE IN WEST AFRICAN ISOLATES OF PLASMODIUM FALCIPARUM
- 1 December 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 330 (8571), 1304-1305
- https://doi.org/10.1016/s0140-6736(87)91195-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN BENINThe Lancet, 1986
- IN VIVO CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN WESTERN AFRICAThe Lancet, 1986
- CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM IN CAMEROONThe Lancet, 1985
- Plasmodium falciparum infection not responding to chloroquine in NigeriaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Single Dose Kinetics of Mefloquine in ManChemotherapy, 1982
- Kinetics of a new antimalarial, mefloquineClinical Pharmacology & Therapeutics, 1979
- Chloroquine-resistant falciparum malaria from AfricaPublished by American Medical Association (AMA) ,1979
- The chemotherapy of rodent malaria, XXXI. The effect of some metabolic inhibitors upon chloroquine-induced pigment clumping (CIPC) inPlasmodium bergheiPathogens and Global Health, 1978
- Mefloquine (WR 142,490) in the Treatment of Human MalariaScience, 1975
- Mefloquine, a clinically useful quinolinemethanol antimalarial which does not significantly bind to DNANature, 1975